logo
Maharashtra govt plans to lift 50-year freeze on new liquor shop licences to boost revenue

Maharashtra govt plans to lift 50-year freeze on new liquor shop licences to boost revenue

Indian Express21 hours ago
In a move aimed at boosting the state revenue, the Maharashtra government is set to lift a 50-year-long freeze on issuing new wine shop licences. According to a report published in Loksatta, the government will issue 328 new licences as per the recommendation of the recently formed committee. If implemented, this will mark the end of a ban in place since 1974 following public resistance.
The move is part of a broader strategy to increase revenue through the Excise Department, which is the fourth-largest contributor to the state's income, generating around Rs 43,000 crore annually.
With welfare schemes like 'Mukhyamantri Majhi Ladki Bahin' demanding significant funding, the government is exploring additional sources of income. If the recommendations of a recently formed committee are implemented, the excise revenue is expected to rise by Rs 14,000 crore per year, Loksatta reported.
However, the decision has sparked controversy and allegations of conflict of interest. A committee to implement these reforms was formed under the chairmanship of Deputy Chief Minister and Excise Minister Ajit Pawar. Critics have raised concerns over this appointment, pointing out that individuals closely associated with Pawar are involved in the liquor industry. A large alcohol manufacturing plant in Baramati, believed to be linked to his associates, has become the focus of this debate.
Industry experts and opposition leaders have questioned the appropriateness of Pawar leading the committee, suggesting it may benefit his close network. Attempts to seek a response from Pawar were unsuccessful at the time of reporting.
The new policy is expected to increase the number of retail liquor shops by 19 per cent across the state. Currently, Maharashtra has 1,713 licensed liquor outlets, a number that has remained unchanged since the 1970s. A previous attempt to increase licences was rolled back due to opposition from prominent socialist leaders like N D Patil and Mrinal Gore.
Under the revised rules, liquor shop licences can now be leased. While purchasing an old license costs nearly Rs 10 crore in the open market, the new licenses will be available for a non-refundable deposit of Rs 1 crore, with the state earning approximately Rs 35 crore annually through licence fees.
Compared to neighbouring states, where there are around six liquor shops per one lakh population, Maharashtra has only about 1.5 per lakh. Other Indian states have seen a consistent 3 per cent annual increase in wine shops, whereas Maharashtra has kept the sector stagnant.
'Given the state's geography and population, increasing the number of outlets is both reasonable and necessary,' Dr Rajgopal Deora, Additional Chief Secretary of the Excise Department, told The Indian Express.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

HUDCO gains after signing MoU with MPUDCL
HUDCO gains after signing MoU with MPUDCL

Business Standard

time21 minutes ago

  • Business Standard

HUDCO gains after signing MoU with MPUDCL

Housing & Urban Development Corporation (HUDCO) rose 1.24% to Rs 233.50 after the company announced that it has signed a memorandum of understanding (MoU) with Madhya Pradesh Urban Development Company (MPUDCL) in Indore. Under the non-binding MoU, HUDCO will provide financial support of Rs 1,00,000 crore over five years for various housing and infrastructure projects in Madhya Pradesh. Besides funding, HUDCO will also offer consulting services and support to build capacity to ensure the effective implementation of the proposed initiatives. Housing & Urban Development Corporation (HUDCO) is primarily engaged in the business of financing housing and urban development activities in the country.

VIP Industries shares slip 5.5% as Dipal Piramal, family offload 32% stake
VIP Industries shares slip 5.5% as Dipal Piramal, family offload 32% stake

Business Standard

time21 minutes ago

  • Business Standard

VIP Industries shares slip 5.5% as Dipal Piramal, family offload 32% stake

VIP Industries Stake Sell: Shares of VIP Industries slipped 5.5 per cent, hitting an intraday low of ₹431.10 on Monday, after promoter group, Dipal Piramal and family, announced the sale of their 32 per cent stake in the company. In a recent exchange filing, the luggage maker stated that the promoters have entered into a definitive agreement with a group of sellers. At 09:30 AM, VIP Industries' shares were trading at ₹434.50, down by 4.92 per cent on the National Stock Exchange. In comparison, the Nifty50 was trading largely flat, albeit in the negative territory, quoting 25,075.05. Around 3.32 million shares have changed hands on the counter, collectively, on the NSE and BSE till the time of writing this report. So far this year, shares of the company have struggled to trade in green, experiencing a drop of 5.12 per cent. VIP Industries Promoter stake sale As per the agreement, Piramals will sell up to 32 per cent of their stake to the Multiples consortium, which includes Samvibhag Securities Private Ltd., Mithun Padam Sacheti, Siddhartha Sacheti and Profitex Shares and Securities Pvt Ltd. This stake sale will trigger an open offer, wherein the new buyers will be acquiring up to 37 million shares (representing 26 per cent of the expanded share capital) from public shareholders, at a price of ₹388 per equity share. This will result in a total payout of around ₹1,437.78 crore, assuming all public shareholders accept the offer. As per the exchange filing, the payment will be made entirely in cash. "We are pleased to welcome the Multiples consortium as strategic partners in the Company. This marks an important step toward reviving the company's strong legacy and helping it regain its foothold in the Indian luggage market, where it has struggled in recent years," said Dilip Piramal, chairman of the company. ALSO READ | VIP Industries Share Price The Indian company is Asia's largest manufacturer of luggage and other travel accessories. VIP Industries was incorporated in 1971 and has over 8000 employees across the globe. However, the shares of the company have remained largely flat on the bourses, signalling muted investor sentiment. On an annual basis, VIP Industries shares have witnessed a mere surge of just 2 per cent on the BSE. Should you buy, hold or sell the stock? The VIP Industries stock, according to chart patterns, is seen trading above its 20-DMA. On the long-term chart, VIP stock is seen facing some resistance around its 100-Month Moving Average, which stands at ₹448; above which the near hurdle is seen at ₹459. On the upside, sustenance above the long-term hurdles can trigger a rally towards ₹542 levels. Intermediate resistance can be anticipated around ₹488 and ₹523 levels. DETAILED TECH STRATEGY HERE

Glenmark Pharma receives warning letter from USFDA for Indore facility
Glenmark Pharma receives warning letter from USFDA for Indore facility

Business Standard

time21 minutes ago

  • Business Standard

Glenmark Pharma receives warning letter from USFDA for Indore facility

Glenmark Pharmaceuticals has announced that it received a warning letter from the U.S. Food and Drug Administration (FDA) for its manufacturing facility in Indore, Madhya Pradesh, India. The USFDA inspection was conducted between 3 February and 14 February 2025. In an official filing, the company stated that it does not anticipate the warning letter will disrupt supply chains or affect revenues generated from the Indore facility. Glenmark emphasized its commitment to addressing the FDAs concerns promptly and working closely with the regulator to resolve the issues. The company further clarified that there were no observations related to data integrity during the inspection. Glenmark reaffirmed its dedication to maintaining the highest quality and compliance standards, including adherence to Current Good Manufacturing Practices (CGMP), across all its facilities. Glenmark Pharmaceuticals is a research-led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology. On a consolidated basis, Glenmark Pharmaceuticals reported a net profit of Rs 4.65 crore in Q4 March 2025 as against a net loss of Rs 1,218.28 crore in Q4 March 2024. Net sales rose 6.77% year-on-year to Rs 3220.13 crore in Q4 March 2025. The scrip shed 0.56% to Rs 2,169.30 on the BSE.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store